Clinical trials

  • M2RLAB for Acute kidney injury (post-cardiac surgery)
  • DATOPOTAMAB DERUXTECAN for Non-small cell lung cancer (non-squamous, locally-advanced or metastatic)
  • Glutathione for Myocardial injury | Pneumonia
  • LIVMONIPLIMAB for Hepatocellular carcinoma (locally advanced or metastatic) | Hepatocellular carcinoma (metastatic)
  • lazertinib for Non-small cell lung cancer (EGFR-mutated) | Advanced or metastatic solid tumors
  • TINLAREBANT for Geographic Atrophy
  • Cemiplimab for Non-small cell lung cancer
  • Etanercept for Juvenile idiopathic arthritis
  • TOMINERSEN for Huntington's disease (prodromal and early manifest)
  • tadalafil for Rectal cancer | Sexual dysfunction
  • CAPIVASERTIB for Breast cancer (hormone receptor-positive, HER2−), locally advanced or metastatic
  • SILDENAFIL for Univentricular heart | Fontan procedure